Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 19;182(4):869–879. doi: 10.1111/bjd.18384

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

(a) Static Physician's Global Assessment (sPGA) 0 or 1 responses at week 24 for the intention‐to‐treat (ITT) population with baseline sPGA ≥ 3, and (b) Dermatology Life Quality Index (DLQI) 0 or 1 responses at week 24 for the ITT population with nonresponder imputation (NRI). FAE, fumaric acid ester; IXE, ixekizumab; MTX, methotrexate; Q2W, every 2 weeks; Q4W, every 4 weeks. *P < 0·05 IXE vs. FAEs, ^¶ P < 0·05 IXE vs. MTX, ^‡ddagger; P < 0·05 MTX vs. FAEs. Prespecified P‐values at 12 and 24 weeks are presented (Hochberg adjusted).